One‐year efficacy and safety of a fixed combination of insulin degludec and liraglutide in patients with type 2 diabetes: results of a 26‐week extension to a 26‐week main trial

AIMS: To confirm, in a 26‐week extension study, the sustained efficacy and safety of a fixed combination of insulin degludec and liraglutide (IDegLira) compared with either insulin degludec or liraglutide alone, in patients with type 2 diabetes. METHODS: Insulin‐naïve adults with type 2 diabetes ran...

Descripción completa

Detalles Bibliográficos
Autores principales: Gough, S. C. L., Bode, B. W., Woo, V. C., Rodbard, H. W., Linjawi, S., Zacho, M., Reiter, P. D., Buse, J. B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744775/
https://www.ncbi.nlm.nih.gov/pubmed/25980900
http://dx.doi.org/10.1111/dom.12498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744775/
https://www.ncbi.nlm.nih.gov/pubmed/25980900
http://dx.doi.org/10.1111/dom.12498

Ejemplares similares